Core B: The Cell Culture Core
Core B: The Cell Culture Core
批准号:
10227012
负责人:
KAREN M RIDGE
金额:
$22.0万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-15 至 2023-07-31
关键词:
AnimalsAttentionB-LymphocytesBiological AssayBiological ModelsBreedingCRISPR/Cas technologyCell Culture TechniquesCell LineCell modelCellsChemicalsCore FacilityDataEmbryoEndothelial CellsEnsureEnterobacteria phage P1 Cre recombinaseEpithelial CellsFibroblastsGene ExpressionGene Expression ProfilingGenerationsGenesGenotypeGoalsHigh-Throughput Nucleotide SequencingHumanHuman ResourcesIndividualIntermediate Filament ProteinsIntermediate FilamentsInvestigationKnock-outKnockout MiceLiverLungMammalian CellMeasuresMechanicsMolecularMouse StrainsMusNull LymphocytesPathway interactionsPhenotypePropertyProtein IsoformsProteinsRNA analysisReagentRecombinantsRegulationResearchResearch PersonnelResolutionResourcesRoleSignal TransductionStructureSystemTamoxifenTechniquesTechnologyTissue HarvestingTissuesTranscriptTranslatingUniversitiesVimentinbasecadherin 5cell motilitycell typecostcost effectivenessdesignexperienceexperimental studyextracellulargenome editinginducible gene expressionknockout animalmechanical propertiesnext generation sequencingnovelprogramspromotersynergismtranscription activator-like effector nucleasestranscriptometranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary: Core B
The Cell Culture Core, designated as Core B, is a centralized facility that provides primary mouse embryonic
fibroblasts, endothelial and epithelial cells isolated from wild-type and genetically modified mice to each of the
five projects. Core B also maintains secondary lung cell lines for the PPG and will generate genome-edited
cells. Core B will use advanced genome-editing technology to produce cells expressing mEmerald-vimentin,
both under the control of its endogenous promoter, as well CRISPR/Cas9-based genome editing to produce
cells lacking vimentin protein. The Core personnel have extensive experience in the isolation of primary mouse
embryonic fibroblasts, tissue-specific fibroblasts, endothelial, and epithelial cells from mouse tissue (e.g. lung
and liver), as well as general cell culture techniques. Centralization of the cell culture facilities will ensure that
continuous supply of high-quality cells will be available to each of the five projects. The consolidated cell
culture facility provides an economical means of isolating and culturing primary and secondary cells. This
translates into reduced overall costs (i.e., personnel, reagents, and animals) and more importantly maintains
the quality of the cells used in research. The Core will also provide investigators several murine strains,
including vimentinfl/fl mice, which will allow investigators to examine cell-specific roles of genes or pathways
using mice expressing Cre recombinase or using tamoxifen-inducible systems. Many of the strains will be used
in more than one project, highlighting the synergy and economies of scale achievable by this Program Project.
These animals will be used to generate cells and tissues for investigations outlined by the project investigators.
In addition, Core B will conduct limited RNA analysis to assess the specific gene expression in vimentin
expressing and vimentin-null cells using the Northwestern University Next-Generation Sequencing (NGS) Core
Facility.
!
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Recovery from Viral Pneumonia
-
批准号:10696954
-
项目类别:
-
资助金额:$275.06万
-
财政年份:2021
-
负责人:KAREN M RIDGE
-
依托单位:
Project 1: Vimentin regulates host response and repair mechanisms to influenza A viral pneumonia
-
批准号:10269674
-
项目类别:
-
资助金额:$53.95万
-
财政年份:2021
-
负责人:KAREN M RIDGE
-
依托单位:
Administrative Core
-
批准号:10696955
-
项目类别:
-
资助金额:$10.96万
-
财政年份:2021
-
负责人:KAREN M RIDGE
-
依托单位:
Mechanisms of Recovery from Viral Pneumonia
-
批准号:10269670
-
项目类别:
-
资助金额:$284.87万
-
财政年份:2021
-
负责人:KAREN M RIDGE
-
依托单位:
Administrative Core
-
批准号:10269671
-
项目类别:
-
资助金额:$11.2万
-
财政年份:2021
-
负责人:KAREN M RIDGE
-
依托单位:
Project 1: Vimentin regulates host response and repair mechanisms to influenza A viral pneumonia
-
批准号:10696962
-
项目类别:
-
资助金额:$51.66万
-
财政年份:2021
-
负责人:KAREN M RIDGE
-
依托单位:
Vimentin-mediated regulation of the inflammasome in acute lung injury
-
批准号:9251880
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2016
-
负责人:KAREN M RIDGE
-
依托单位:
Tissue and neurobehavioral phenotyping core
-
批准号:10417058
-
项目类别:
-
资助金额:$29.9万
-
财政年份:2015
-
负责人:KAREN M RIDGE
-
依托单位:
Tissue and neurobehavioral phenotyping core
-
批准号:10197741
-
项目类别:
-
资助金额:$30.21万
-
财政年份:2015
-
负责人:KAREN M RIDGE
-
依托单位:
Tissue and neurobehavioral phenotyping core
-
批准号:10620765
-
项目类别:
-
资助金额:$29.41万
-
财政年份:2015
-
负责人:KAREN M RIDGE
-
依托单位:
Role of vimentin in influenza A-induced acute lung injury
-
批准号:8775974
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2014
-
负责人:KAREN M RIDGE
-
依托单位:
2014 Intermediate Filaments Gordon Research Conference and Gordon Research Semina
-
批准号:8718603
-
项目类别:
-
资助金额:$2.25万
-
财政年份:2014
-
负责人:KAREN M RIDGE
-
依托单位:
Role of vimentin in influenza A-induced acute lung injury
-
批准号:8894080
-
项目类别:
-
资助金额:$38.05万
-
财政年份:2014
-
负责人:KAREN M RIDGE
-
依托单位:
Effects of Hypoxia on Alveolar Epithelial Cytoskeleton
-
批准号:7824760
-
项目类别:
-
资助金额:$1.87万
-
财政年份:2009
-
负责人:KAREN M RIDGE
-
依托单位:
Core--Cell culture and physiology
-
批准号:7435399
-
项目类别:
-
资助金额:$39.41万
-
财政年份:2007
-
负责人:KAREN M RIDGE
-
依托单位:
Effects of Hypoxia on Alveolar Epithelial Cytoskeleton
-
批准号:6857783
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2005
-
负责人:KAREN M RIDGE
-
依托单位:
Effects of Hypoxia on Alveolar Epithelial Cytoskeleton
-
批准号:7577413
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2005
-
负责人:KAREN M RIDGE
-
依托单位:
Effects of Hypoxia on Alveolar Epithelial Cytoskeleton
-
批准号:7012323
-
项目类别:
-
资助金额:$32.02万
-
财政年份:2005
-
负责人:KAREN M RIDGE
-
依托单位:
Effects of Hypoxia on Alveolar Epithelial Cytoskeleton
-
批准号:8473903
-
项目类别:
-
资助金额:$35.61万
-
财政年份:2005
-
负责人:KAREN M RIDGE
-
依托单位:
Effects of Hypoxia on Alveolar Epithelial Cytoskeleton
-
批准号:7339903
-
项目类别:
-
资助金额:$31.05万
-
财政年份:2005
-
负责人:KAREN M RIDGE
-
依托单位:
国内基金
海外基金
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郑巧
-
依托单位:
Ultrasomics-Attention孪生网络早期精准评估肝内胆管癌免疫治疗的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈立达
-
依托单位: